調查批次:CHT2018-01 | 檢體寄出日期:2018-06-04 | 報告回收截止日期:2018-06-11 | 回收份數:22 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
2.58 |
-0.28 |
-9.8 |
-1.2 |
0.3 |
-41 |
1.65 |
-0.18 |
-9.8 |
-1.2 |
0.2 |
-41 |
RH07b | RH07 | 4 |
2 |
3 |
2.58 |
-0.28 |
-9.8 |
-1.2 |
0.3 |
-41 |
1.47 |
-0.36 |
-19.7 |
-2.5 |
-0.4 |
-82 |
RH14 | RH14 | 4 |
2 |
3 |
3.25 |
0.39 |
13.6 |
1.7 |
1.5 |
57 |
1.98 |
0.15 |
8.2 |
1.0 |
1.3 |
34 |
RH15 | RH15 | 4 |
2 |
5 |
2.39 |
-0.47 |
-16.4 |
-2.1 |
0.0 |
-68 |
1.71 |
-0.12 |
-6.6 |
-0.8 |
0.4 |
-27 |
CL009 | CL009 | 3 |
2 |
5 |
2.23 |
-0.63 |
-22.0 |
-2.8 |
-0.3 |
-92 |
1.74 |
-0.09 |
-4.9 |
-0.6 |
0.5 |
-21 |
CL010 | CL010 | 3 |
2 |
5 |
2.10 |
-0.76 |
-26.6 |
-3.3 |
-0.5 |
-111 |
1.42 |
-0.41 |
-22.4 |
-2.8 |
-0.6 |
-94 |
CL012 | CL012 | 4 |
2 |
3 |
1.61 |
-1.25 |
-43.7 |
-5.5 |
-1.4 |
-182 |
1.17 |
-0.66 |
-36.1 |
-4.5 |
-1.4 |
-151 |
Median of RIA Group |
2.39 |
1.65 |
||||||||||||||
Range of RIA Group |
1.61 - 3.25 |
1.17 - 1.98 |
||||||||||||||
Robust mean of RIA Group |
2.39 ( n = 7 ) |
1.59 ( n = 7 ) |
||||||||||||||
Robust SD of RIA Group |
0.573 |
0.297 |
||||||||||||||
CV of RIA Group |
24.0% |
18.7% |
||||||||||||||
Median of European RIA Labs |
2.46 ( n = 103 ) |
1.71 ( n = 104 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.24 - 2.84 |
1.59 - 1.90 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 8 |
4 |
9 |
2.07 |
-0.79 |
-27.6 |
-3.4 |
-1.2 |
-115 |
1.45 |
-0.38 |
-20.8 |
-2.6 |
-0.8 |
-87 |
RH02c | RH02 | 2 |
4 |
1 |
2.30 |
-0.56 |
-19.6 |
-2.4 |
-0.6 |
-82 |
1.51 |
-0.32 |
-17.5 |
-2.2 |
-0.6 |
-73 |
RH06 | RH06 | 4 |
4 |
9 |
2.94 |
0.08 |
2.8 |
0.3 |
1.1 |
12 |
2.02 |
0.19 |
10.4 |
1.3 |
1.6 |
43 |
RH07a | RH07 | 3 |
4 |
2 |
2.41 |
-0.45 |
-15.7 |
-2.0 |
-0.3 |
-66 |
1.45 |
-0.38 |
-20.8 |
-2.6 |
-0.8 |
-87 |
RH12 | RH12 | 8 |
4 |
2 |
2.56 |
-0.30 |
-10.5 |
-1.3 |
0.1 |
-44 |
1.57 |
-0.26 |
-14.2 |
-1.8 |
-0.3 |
-59 |
RH15b | RH15b | 7 |
4 |
13 |
2.88 |
0.02 |
0.7 |
0.1 |
0.9 |
3 |
1.89 |
0.06 |
3.3 |
0.4 |
1.1 |
14 |
RH19 | RH19 | 2 |
4 |
2 |
2.49 |
-0.37 |
-12.9 |
-1.6 |
-0.1 |
-54 |
1.46 |
-0.37 |
-20.2 |
-2.5 |
-0.8 |
-84 |
RH20 | RH20 | 4 |
4 |
7 |
2.75 |
-0.11 |
-3.8 |
-0.5 |
0.6 |
-16 |
1.71 |
-0.12 |
-6.6 |
-0.8 |
0.3 |
-27 |
CL005 | CL005 | 2 |
4 |
9 |
3.08 |
0.22 |
7.7 |
1.0 |
1.5 |
32 |
1.96 |
0.13 |
7.1 |
0.9 |
1.4 |
30 |
CL006a | CL006 | 7 |
4 |
7 |
2.49 |
-0.37 |
-12.9 |
-1.6 |
-0.1 |
-54 |
1.67 |
-0.16 |
-8.7 |
-1.1 |
0.1 |
-37 |
CL008 | CL008 | 4 |
4 |
2 |
2.49 |
-0.37 |
-12.9 |
-1.6 |
-0.1 |
-54 |
1.49 |
-0.34 |
-18.6 |
-2.3 |
-0.6 |
-78 |
CL011 | CL011 | 2 |
4 |
13 |
2.91 |
0.05 |
1.7 |
0.2 |
1.0 |
7 |
1.89 |
0.06 |
3.3 |
0.4 |
1.1 |
14 |
CL013b | CL013b | 7 |
4 |
1 |
1.81 |
-1.05 |
-36.7 |
-4.6 |
-1.9 |
-153 |
1.41 |
-0.42 |
-23.0 |
-2.9 |
-1.0 |
-96 |
CL014b | CL014 | 7 |
4 |
1 |
2.17 |
-0.69 |
-24.1 |
-3.0 |
-1.0 |
-100 |
1.42 |
-0.41 |
-22.4 |
-2.8 |
-0.9 |
-94 |
CL015b | CL015b | 3 |
4 |
7 |
2.49 |
-0.37 |
-12.9 |
-1.6 |
-0.1 |
-54 |
1.68 |
-0.15 |
-8.2 |
-1.0 |
0.2 |
-34 |
Median of CLIA Group |
2.49 |
1.57 |
||||||||||||||
Range of CLIA Group |
1.81 - 3.08 |
1.41 - 2.02 |
||||||||||||||
Robust mean of CLIA Group |
2.53 ( n = 15 ) |
1.64 ( n = 15 ) |
||||||||||||||
Robust SD of CLIA Group |
0.372 |
0.236 |
||||||||||||||
CV of CLIA Group |
14.7% |
14.4% |
||||||||||||||
Median of European CLIA Labs |
2.93 ( n = 1026 ) |
1.85 ( n = 1056 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.22 - 3.14 |
1.48 - 1.97 |
||||||||||||||
Median of All Labs |
2.49 |
1.61 |
||||||||||||||
Range of All Labs |
1.61 - 3.25 |
1.17 - 2.02 |
||||||||||||||
Robust mean of All Labs |
2.49 ( n = 22 ) |
1.63 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
0.398 |
0.241 |
||||||||||||||
CV of All Labs |
16.0% |
14.8%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.86 |
1.83 |
||||||||||||||
uXa |
0.016 |
0.008 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.24 - 3.14 |
1.48 - 1.97 |
||||||||||||||
Mean of All European Labs |
2.74 ( n = 1197 ) |
1.75 ( n = 1216 ) |
||||||||||||||
SD of All European Labs |
0.436 |
0.228 |
||||||||||||||
CV of All European Labs |
16.0% |
13.0% |
||||||||||||||
SD for proficiency assessment ( σp ) |
0.229 |
0.146 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL014b, CL015b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL013b, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, CL015b, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2018-06-15